Physician

Peter G Hovland, MD PHD

According to 2025 Medicare claims, Peter Hovland, MD PHD (NPI: 1720047210) practices ophthalmology in the Denver-Aurora-Centennial, CO market, with the plurality of this provider's patient population coming from Arapahoe, CO. This provider's primary affiliated billing organization is COLORADO RETINA ASSOCIATES, PLLC (NPI: 1790876159; TIN: 203288374) and primary practice location at 80228-2271.

Hovland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 572 traditional Medicare patients, billed 28,380 HCPCS/CPT codes, and received $2,613,138 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 274 prescription claims across 98 beneficiaries totaling $17,976 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 12 records totaling $454. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $705,852 to $2,613,138. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $16,499 and ending at $17,976. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $705,852 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $761,466 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,003,880 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,363,898 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,215,533 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,298,555 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,514,115 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,716,097 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,842,892 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,613,138 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154764,850$705,852
20164855,649$761,466
20176057,606$1,003,880
20186528,881$1,363,898
20195857,671$1,215,533
20206227,895$1,298,555
20216178,001$1,514,115
20226098,024$1,716,097
202355715,879$1,842,892
202457228,380$2,613,138

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$23K2015 Drug cost: $16,499 (USD; Tot_Drug_Cst)2016 Drug cost: $14,026 (USD; Tot_Drug_Cst)2017 Drug cost: $19,913 (USD; Tot_Drug_Cst)2018 Drug cost: $18,667 (USD; Tot_Drug_Cst)2019 Drug cost: $18,148 (USD; Tot_Drug_Cst)2020 Drug cost: $20,832 (USD; Tot_Drug_Cst)2021 Drug cost: $19,264 (USD; Tot_Drug_Cst)2022 Drug cost: $13,708 (USD; Tot_Drug_Cst)2023 Drug cost: $23,066 (USD; Tot_Drug_Cst)2024 Drug cost: $17,976 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201592285$16,499
2016113309$14,026
2017136351$19,913
2018121302$18,667
2019108281$18,148
2020108330$20,832
2021102318$19,264
2022110274$13,708
2023100287$23,066
202498274$17,976

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1121,054$658
67028Injection of drug into eye2251,155$108
92014Established patient complete exam of visual system369460$99
99426Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month97503$53
92134Imaging of retina5351,633$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate533,663$2,043
DifluprednateDifluprednate12565$1,864
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat664,984$839
Ketorolac TromethamineKetorolac Tromethamine17890$532
AcetazolamideAcetazolamide11502$446

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$454Genentech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Peter G. Hovland, MD PHD?

Tedicare shows public-source Medicare data for Peter G. Hovland, MD PHD (NPI 1720047210), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter G. Hovland, MD PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter G. Hovland, MD PHD?

Peter G. Hovland, MD PHD is linked to COLORADO RETINA ASSOCIATES, PLLC (billing NPI 1790876159) in the available physician profile data.

Does Peter G. Hovland, MD PHD have Open Payments data?

Peter G. Hovland, MD PHD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.